PIPELINE
Our Portfolio
We work on the best targets for patients
We have an exciting pipeline of novel, differentiated small molecules against membrane proteins and intracellular complexes – Solute Carriers, GPCRs, Inflammasome – with a focus on immunological and orphan diseases. We select targets with low translation risk through genetic association, pathway linked patient selection or immune signature stratification.

Click Target For More Info

Description Progress
Target Type Indication Discovery Lead ID Lead Optimisation Preclinical
MC2GPCROrphan endocrine disorders
GPR65GPCRIBD
GasderminIntracellular complexesBroad immunology
KCC2Solute carriersEpilepsy including rare epilepsy
SLC15A4Solute carriersLupus and other IFN-opathies
MC2
Insurmountable ACTH antagonism for a best-in-class profile in rare endocrine disorders.
GPR65
First-in-class molecules driving novel anti-inflammatory biology in Inflammatory Bowel Disease.
Gasdermin
First-in-class Gasdermin D inhibitors – a pipeline in a product.
KCC2
First-in-class solute carrier activator reducing seizures in epilepsy including rare epilepsies
SLC15A4
First-in-class solute carrier inhibitor against a highly validated target in Lupus and other IFN-opathies

PIPELINE

Need more information about our pipeline?

Contact Us